Please login to the form below

Not currently logged in
Email:
Password:

Lucid Group acquires HealthCare21

Expands reach in UK, Asia Pacific and Middle East

Lucid Group HealthCare21

From left to right: Cliff Wyatt, HealthCare21 managing director, Jan Steele, Lucid Group COO and co-founder and Dennis O’Brien, Lucid Group CEO

Lucid Group, a global healthcare communications agency, has acquired consultancy HealthCare21. 

Currently, Lucid has five subsidiaries in its group – Bluedog, Leading Edge, Lighthouse, Lucid partners and ViVid. The most recent acquisition was of Bluedog, the London-based digital and creative agency, in February 2019.

“This is a perfect match and builds on Lucid’s leadership position in medical communication. We have developed a reputation for excellent strategic consultancy, impactful medcomms, digital excellence and creative execution. HealthCare21 brings further scientific and editorial expertise to increase our offering to our clients and bring more opportunities for our teams,” said Dennis O’Brien, co-founder and CEO, Lucid Group.

HealthCare21 has been producing healthcare materials and programmes for clients for over 23 years. It’s UK office is based in Macclesfield, Cheshire, with additional offices in Singapore and Dubai.

“I am delighted that HealthCare21 is joining Lucid Group. With our strongest ever year in 2018, this is a good time for us to capitalise on this momentum, benefit from better infrastructure and additional capabilities like behaviour change and establish ourselves further as partner of choice for our clients,” said Cliff Wyatt, managing director, HealthCare21.

The new relationship will see Lucid expand its offering and develop its expertise. It will gain a significant presence in the North West of the UK, where HealthCare21 has its headquarters. The presence of offices in Singapore and Dubai will also allow expansion into these location.

12th September 2019

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics